Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCUMBERLAND PHARMACEUTICALS INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CUMBERLAND PHARMACEUTICALS INC

$7.02Close · Oct 9, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $166.46K. Net result −$4.27M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $166.46K. Running result $166.46K. Revenue: $166.46K.
  • Research and development: −$772.16K. Running result −$605.7K.
  • General and administrative: −$2.55M. Running result −$3.15M.
  • Amortization: −$7.15K. Running result −$3.16M.
  • Operating income: −$3.16M. Running result −$3.16M.
  • Other income: $60.16K. Running result −$3.1M.
  • Pre-tax loss: −$3.1M. Running result −$3.1M.
  • Income tax expense: −$3.87K. Running result −$3.1M.
  • Net loss: −$4.27M. Running result −$4.27M.